"I like the way the new SmartChem design looks and presents information. It is very intuitive and helps in saving a considerable amount of time."

- Sourcing Manager, One of the top 10 Pharma Companies, USA

"ROW2’s RouteDesign report gave us novel synthetic routes suitable for commercial scale that we had not considered before, and therefore, added to our team's knowledge. We would definitely use this service again."

- Head of Process Research, One of the leading Pharma companies

ROW2 World:

• SmartChem launched in an entirely new design: ROW2 kicked off the year 2009 with the launch of SmartChem in an entirely new design. With an aim to reduce the search time, to ensure intelligent searching and smooth navigation, SmartChem was re-designed into a more user-friendly interface. We thank SmartChem users for their encouraging feedback on the new design.





• SmartChem strengthened further to help customers confront today’s challenges: The Chemicals and Life Sciences industry has been facing challenges such as REACH regulations, getting “credible” suppliers, negotiating best deals, working on complex molecules etc. SmartChem has been enriched further to help its customers confront these challenges. REACH Corner in SmartChem acts as a ready reckoner for all REACH related key information. Alerts on REACH High Concern and Prioritized Substances caution SmartChem users on the consumption of these chemicals. Details on Certificate of Suitability (CEP) holders, Drug and Veterinary Master Files (DMF/VMF) make searches for credible sources more focused and targeted. Focused updations of latest molecules, Company-wise Products, Details on Innovators & Developers, etc. are some more value-adding SmartChem enrichments.
  
  It’s a matter of great pride for us to share with our readers that SmartChem has successfully achieved a landmark of serving over 750 users from around 20 countries worldwide. We thank all our customers for their trust and support.





• RouteDesign continues to move on its success path: Our flagship service, RouteDesign continues to help customers from Pharmaceutical, Biotech, Chemical and Agro industries generate Intellectual Property, get wider scalable route options and successfully handle multiple challenges of Process Chemistry. In addition, Route2Practice, the service that reduces to practice routes developed in the RouteDesign projects, is also receiving applauds from the customers.





• ROW2 marked its presence at various events: It was our 8th year of participation at Informex’09 as an exhibitor and it turned out to be a truly action packed and successful event for us. ROW2 was also present at other major events such as Chemspec Europe, Chemspec India, CPhI Worldwide, CPhI India, OPR&D, ChemOutsourcing, etc.





• CI2E’s 5th year celebrations: CI2E Quarterly celebrated the 5th year of its association with its readers this year. For the last 5 years, it has been connecting with people as a Compendium of Information, Interaction and Entertainment. CI2E’s 5th year celebrations brought many exciting contests and offers for our readers, which they enjoyed thoroughly. Read on and participate in the “My New Year Resolution” contest NOW!





• Celebrations'09: ROW2 celebrated its 4th annual Process Research Chemists Day on November 10, 2009 and Thanksgiving on November 26, 2009 with its RouteDesign and SmartChem customers.

Important Events: Jan’10 to March’10

January:
20-22 : OPR&D: San Diego, USA
25-26 : BIO Asia 2010: Tokyo, Japan

February:
16-19 : Informex: San Francisco, USA

March:
08-10 : Bio Europe Spring: Barcelona, Spain

Summary of Featured Articles in 2009:

Catch glimpses of the articles that featured in the 2009 CI2E special issues.

ROW2 thanks all the industry experts who have shared their thoughts with CI2E Quarterly readers worldwide through this section.

Issue 3: September 2009

Impact of recessionary environment on the Biotech and Life Sciences Industry in Europe

Evaluating the impact of the global economic downturn, the editor of Chemistry & Industry, Neil Eisberg describes the problems and pressures faced by the European Biotech, Pharma and Agrochemical companies.

To read the full article click here.


Issue 2: June 2009

How to approach a Substance Information Exchange Forum (SIEF) formed under REACH legislation?

With the first REACH Pre-registration date approaching in December 2010, Rob Rutjes of Royal Haskoning lists down the Do’s and Don’ts of going through the entire pre-registration process including approaching SIEFs.

To read the full article click here.


Issue 1: Mar 2009

The impact of the recessionary environment on the Biotech Industry in Italy

Fabrizio Conicella of BioIndustry Park Canavese gives details as to how the economic crisis in Italy affected the Biotech Industry and what measures companies took to cope up with crisis.

To read the full article click here.

ROW2 Picks of the Quarter:

Patent Rules Rescinded
Published in C&E News: October’09 issue

To manage the growing backlogs of unexamined patent applications, USPTO has withdrawn some very controversial regulations imposed from August 2007. Read this article to gather more information.

Biotech Remains Upbeat During the Summer
Published in BioPharm.com: Oct’09 issue

Breaking the traditional laws of staying quiet during the summer months, Biotech sector experienced solid gain during June – August period. Read this interesting article to know more details.

Following are the top 3 articles from our past 2009 issues, which were appreciated by our readers.

Big Pharma Money Spent on Marketing Exceeds Drug Development Costs
Published in NaturalNews.com: Feb, 2009 issue

An interesting article that reveals how US is spending more money in marketing a drug rather than developing new drugs.

Chemical Earnings Continue To Slide
Published in C&E News: April’09 issue

This article sheds light on how the deteriorating consumer and industrial demand is impacting earnings in the chemical industry.

So Much for Summer Slump: July Financings Keep Pace
Published in BioWorld Today: Aug’09 issue

Good news for biotech industry! In spite of the global economic downturn, biotech industry with the help of public company financings, outpaced the last year’s financial drawings. Read the article to know the details.

New Year Recreation:

With the season of Celebration and Enjoyment, we are pleased to share with you some Funny New Year Resolutions:

1. I will drive more carefully; people are starting to notice the dozens of dents in my car.

2. My New Year resolution is: 1024 by 968 pixels!
   

3. Learn what the word "resolution" means.
   

4. I promise to stick to these resolutions for more than a week.
   

5. I will avoid taking a bath whenever possible and conserve more water.
   

6. I will do less laundry and use more deodorant.
   

7. I will find out why the correspondence course on "Mail Fraud" that I purchased never showed up.
   

8. I resolve to work with neglected children -- my own.
   

*Conditions Apply

Chemistry and Pharma World 2009 Highlights:

The 2009 Nobel Prize in Chemistry was jointly awarded to Ada E. Yonath, Thomas A. Steitz, and Venkatraman Ramakrishnan for studies of the structure and function of the ribosome, the protein-making factory of cells.

Source: Nobelprize.org

Popular brands lost patent protection in 2009:

- Valtrex, Mepron and Imitrex (GSK)
- Prevacid (Takeda)
- Migranal (Novartis)
- Keppra (UCB)

Interesting Facts about New Year:

• New Year is the oldest of all holidays, as it was first observed in ancient Babylon 4000 years ago.
• The Roman senate declared January 1 as the New Year in 153 BC. Though this date saw major tampering, it was Julius Caesar who again declared January 1 in Julian calendar as the New Year, in 46 BC.
• The Spanish ritual on New Year's eve is to eat twelve grapes at midnight. The tradition is meant to secure twelve happy months in the coming year.